Advertisement
Advertisement
U.S. markets close in 1 hour 1 minute
Advertisement
Advertisement
Advertisement
Advertisement

Adverum Biotechnologies, Inc. (ADVM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.7850+0.0250 (+1.42%)
As of 02:58PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Engulfing Line (Bullish)

Engulfing Line (Bullish)

Previous Close1.7600
Open1.7600
Bid1.7700 x 3000
Ask1.7800 x 3000
Day's Range1.6900 - 1.8100
52 Week Range1.6900 - 14.7900
Volume1,361,017
Avg. Volume2,169,068
Market Cap175.201M
Beta (5Y Monthly)1.14
PE Ratio (TTM)N/A
EPS (TTM)-1.5200
Earnings DateFeb 28, 2022 - Mar 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ADVM

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Adverum Biotechnologies, Inc.
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
    Rating
    Fair Value
    Economic Moat
    9 months agoMorningstar
View more
Advertisement
Advertisement